Jump Financial, LLC Relay Therapeutics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.5 - $12.07 $77,370 - $124,514	10,316 New	10,316 $85,000
Q3 2023 Nov 07, 2023	SELL	$8.24 - $12.97 $109,699 - $172,669	-13,313 Reduced 11.43%	103,194 $867,000
Q2 2023 Aug 07, 2023	BUY	$9.99 - $18.27 $1.16 Million - $2.13 Million	116,507 New	116,507 $1.46 Million
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $1.31 Million - $2.22 Million	92,413 New	92,413 $1.38 Million
Q1 2022 May 12, 2022	SELL	$20.26 - $32.36 $216,782 - $346,252	-10,700 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$26.0 - $37.03 $1.54 Million - $2.2 Million	-59,400 Reduced 84.74%	10,700 $329,000
Q3 2021 Nov 12, 2021	BUY	$29.75 - $37.99 $1.55 Million - $1.97 Million	51,975 Added 286.76%	70,100 $2.21 Million
Q2 2021 Aug 13, 2021	BUY	$27.5 - $38.19 $498,437 - $692,193	18,125 New	18,125 $663,000

183

127M

1.7K

18K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $780M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.